Drug-Induced Podocytopathies: Report of Four Cases and Review of the Literature

Overview

Journal Life (Basel)

Specialty Biology

Date 2023 Jun 28

PMID 37374047

Authors

Diamanto Athanasopoulou

Sophia Lionaki

Chrysanthi Skalioti

George Liapis

Panayiotis Vlachoyiannopoulos

Ioannis Boletis

Affiliations

Soon will be listed here.

Abstract

Kidney injury due to medications is a well-known clinical entity. Although drug-induced tubulointerstitial disease is commonly encountered, there are few reports in the literature associated with glomerular injury due to medications. The recognition of this type of kidney injury is crucial, as rapid discontinuation of the offending agent is critical to maximizing the likelihood of quick and effective renal function recovery. In this article, we present four cases that presented with nephrotic syndrome and were diagnosed with biopsy-proven podocytopathies, associated with exposure to a certain medication. All of them experienced complete resolution of nephrotic syndrome within days or weeks after discontinuation of the offending drug. We also present the data, which were found in a Medline search from the year 1963 until the present, regarding cases with podocytopathies associated with penicillamine, tamoxifen and the combination of pembrolizumab-axitinib, including only adult cases from the English literature. The Medline search revealed nineteen cases of penicillamine-induced minimal-change disease (MCD), one case of tamoxifen-induced MCD, and none associated with pembrolizumab-axitinib therapy. We also searched for the largest studies and meta-analyses regarding drug-induced podocytopathies after a Medline search from 1967 to the present of the English literature.

References

Ravnskov U . Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. Br J Clin Pharmacol. 1999; 47(2):203-10. PMC: 2014171. DOI: 10.1046/j.1365-2125.1999.00869.x. View

Mielczarek L, Brodziak A, Sobczuk P, Kawecki M, Cudnoch-Jedrzejewska A, Czarnecka A . Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function. Cancer Chemother Pharmacol. 2021; 87(6):723-742. PMC: 8110505. DOI: 10.1007/s00280-021-04260-y. View

Neugarten J, Gallo G, Baldwin D . Rifampin-induced nephrotic syndrome and acute interstitial nephritis. Am J Nephrol. 1983; 3(1):38-42. DOI: 10.1159/000166685. View

Habib G, Saliba W, Nashashibi M, Armali Z . Penicillamine and nephrotic syndrome. Eur J Intern Med. 2006; 17(5):343-8. DOI: 10.1016/j.ejim.2006.03.001. View

Nanke Y, Akama H, Terai C, Kamatani N . Rapidly progressive glomerulonephritis with D-penicillamine. Am J Med Sci. 2001; 320(6):398-402. DOI: 10.1097/00000441-200012000-00008. View

Markowitz G, Radhakrishnan J, Kambham N, Valeri A, Hines W, DAgati V . Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol. 2000; 11(8):1439-1448. DOI: 10.1681/ASN.V1181439. View

Catanuto P, Doublier S, Lupia E, Fornoni A, Berho M, Karl M . 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int. 2009; 75(11):1194-1201. DOI: 10.1038/ki.2009.69. View

Letavernier E, Bruneval P, Mandet C, Duong van Huyen J, Peraldi M, Helal I . High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol. 2007; 2(2):326-33. DOI: 10.2215/CJN.03751106. View

Kyndt X, Ducq P, Bridoux F, Reumaux D, Makdassi R, Gheerbrant J . [Extracapillary glomerulonephritis with anti-myeloperoxidase antibodies in 2 patients with systemic scleroderma treated with penicillamine D]. Presse Med. 1999; 28(2):67-70. View

10.

Santella R, Rimmer J, MacPherson B . Focal segmental glomerulosclerosis in patients receiving lithium carbonate. Am J Med. 1988; 84(5):951-4. DOI: 10.1016/0002-9343(88)90077-0. View

11.

Merida E, Praga M . NSAIDs and Nephrotic Syndrome. Clin J Am Soc Nephrol. 2019; 14(9):1280-1282. PMC: 6730519. DOI: 10.2215/CJN.08090719. View

12.

Kim J, Kim K, Choi E . Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report. Medicine (Baltimore). 2018; 97(22):e10556. PMC: 6392561. DOI: 10.1097/MD.0000000000010556. View

13.

Frazier K, Obert L . Drug-induced Glomerulonephritis: The Spectre of Biotherapeutic and Antisense Oligonucleotide Immune Activation in the Kidney. Toxicol Pathol. 2018; 46(8):904-917. DOI: 10.1177/0192623318789399. View

14.

Praga M, Gonzalez E . Acute interstitial nephritis. Kidney Int. 2010; 77(11):956-61. DOI: 10.1038/ki.2010.89. View

15.

Steiner A, Terplan M, Paulson R . Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis. Hum Reprod. 2005; 20(6):1511-5. DOI: 10.1093/humrep/deh840. View

16.

Park D, Lee S, Jeong H, Yoo T, Kang S, Oh H . Rifampicin-induced minimal change disease is improved after cessation of rifampicin without steroid therapy. Yonsei Med J. 2015; 56(2):582-5. PMC: 4329376. DOI: 10.3349/ymj.2015.56.2.582. View

17.

Semeniuk-Wojtas A, Lubas A, Stec R, Szczylik C, Niemczyk S . Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients. Int J Mol Sci. 2016; 17(12). PMC: 5187873. DOI: 10.3390/ijms17122073. View

18.

Senthil Kumar R, Srinivasa Prasad N, Tirumavalavan S, Fernando M . D-penicillamine-induced membranous nephropathy. Indian J Nephrol. 2014; 24(3):195-6. PMC: 4127844. DOI: 10.4103/0971-4065.132024. View

19.

Pham A, Ye D, Pal S . Overview and management of toxicities associated with systemic therapies for advanced renal cell carcinoma. Urol Oncol. 2015; 33(12):517-27. DOI: 10.1016/j.urolonc.2015.07.020. View

20.

Nanke Y, Akama H, Terai C, Hara M, Kamatani N . [MPO-ANCA positive rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with D-penicillamine]. Nihon Rinsho Meneki Gakkai Kaishi. 2000; 22(5):354-9. DOI: 10.2177/jsci.22.354. View